VILYA
Updates & Highlights
Editor’s pick: Vilya Therapeutics
Editor’s pick: Vilya Therapeutics
Nature · 9 months ago
Vilya
Vilya
ACS Publications · over 1 year ago
With $71M in funding, Seattle biotech Vilya looks to get 'close to the clinic'
With $71M in funding, Seattle biotech Vilya looks to get 'close to the clinic'
The Business Journals · almost 2 years ago
Recent Openings
View all 2 jobsAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Generous PTO
Paid time off
Competitive Salary
Market-rate compensation
Remote Work
Work from anywhere flexibility
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Vilya?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
13 recentEditor’s pick: Vilya Therapeutics
Editor’s pick: Vilya Therapeutics
Nature · 9 months ago
Vilya
Vilya
ACS Publications · over 1 year ago
With $71M in funding, Seattle biotech Vilya looks to get 'close to the clinic'
With $71M in funding, Seattle biotech Vilya looks to get 'close to the clinic'
The Business Journals · almost 2 years ago
Vilya Closes $71 Million Series A
Vilya Closes $71 Million Series A
citybiz · almost 2 years ago
Biotech company Vilya lands cash for disease-fighting 'macrocycles'
Biotech company Vilya lands cash for disease-fighting 'macrocycles'
The Business Journals · almost 2 years ago
Finding Goldilocks Peptides: Investing in Vilya
Finding Goldilocks Peptides: Investing in Vilya
Madrona · almost 2 years ago
NVIDIA and top VC firms invest in Vilya, a biotech spinout from Seattle's Institute for Protein Design
NVIDIA and top VC firms invest in Vilya, a biotech spinout from Seattle's Institute for Protein Design
GeekWire · almost 2 years ago
Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines
Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines
Menlo Ventures · almost 2 years ago
Victor "Vilya" Nalibotski Obituary (2024) - Niantic, CT - Thomas L. Neilan & Sons Funeral Home - New London
Victor "Vilya" Nalibotski Obituary (2024) - Niantic, CT - Thomas L. Neilan & Sons Funeral Home - New London
Legacy obituary · about 2 years ago
Vilya Appoints Cyrus Harmon, Ph.D., As Chief Executive Officer
Vilya Appoints Cyrus Harmon, Ph.D., As Chief Executive Officer
citybiz · over 2 years ago
With $50M, Vilya’s Peptides Aim to Transcend Cells’ Lipid Membrane
With $50M, Vilya’s Peptides Aim to Transcend Cells’ Lipid Membrane
BioSpace · over 3 years ago
Arch builds bridge to new class of medicines, leading $50M investment in the AI-enabled Vilya
Arch builds bridge to new class of medicines, leading $50M investment in the AI-enabled Vilya
Fierce Biotech · over 3 years ago
Vilya emerges to target disease biology
Vilya emerges to target disease biology
Labiotech.eu · over 3 years ago